In one paragraphArticle in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
14 authors.
Ariel J Hernandez-LeyvaDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0003-2427-3727 Amalia Z BernaDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0003-4932-5415 Yang LiuDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Anne L RosenDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0002-7656-3382 Michael A LintDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0002-3536-1311 Samantha A WhitesideDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Natalia JaegerDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0003-2875-8297 Ryan T McDonoughDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Nikhilesh JoardarDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0002-6460-0377 Jesús Santiago-BorgesDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0002-4710-3993 Christopher P TomeraDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0009-0007-7032-6507 Audrey R Odom JohnDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-8395-8537 Andrew L KauDivision of Allergy and Immunology, Department of Medicine and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0002-9386-3766 Funding
NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8MBreathprinting as a window into gut microbiome chemoecologyR01HD109963 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI Andrew Leon Kau, Audrey Ragan Odom John · 2022 to 2026
$3.4MMicrobial Origin of Breath Volatile MetabolitesR21AI154370 · NIAID · WASHINGTON UNIVERSITY · PI KAU, ANDREW LEON, ODOM JOHN, AUDREY RAGAN · 2020 to 2021
$473kImpact of gut microbial metabolism on host breath volatilesF30DK127584 · NIDDK · WASHINGTON UNIVERSITY · PI HERNANDEZ-LEYVA, ARIEL JOSE · 2021 to 2023
$91kNIAID NIH HHS R21 AI154370NICHD NIH HHS R01 HD109963NIDDK NIH HHS F30 DK127584NIGMS NIH HHS T32 GM007200
6 · The paper itselfAbstract
The gut microbiota is widely implicated in host health and disease, inspiring translational efforts to implement our growing body of knowledge in clinical settings. However, the need to characterize gut microbiota by its genomic content limits the feasibility of rapid, point-of-care diagnostics. The microbiota produces a diverse array of xenobiotic metabolites that disseminate into tissues, including volatile organic compounds (VOCs) that may be excreted in breath. We hypothesize that breath contains gut microbe-derived VOCs that inform the composition and metabolic state of the microbiota. To explore this idea, we compared the breath volatilome and fecal gut microbiomes of 27 healthy children and found that breath VOC composition is correlated with gut microbiomes. To experimentally interrogate this finding, we devised a method for capturing exhaled breath from gnotobiotic mice. Breath volatiles are then profiled by gas-chromatography mass-spectrometry (GC-MS). Using this novel methodology, we found that the murine breath profile is markedly shaped by the composition of the gut microbiota. We also find that VOCs produced by gut microbes in pure culture can be identified
Identifiers
PMID39132488
PMCPMC11312666
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390